摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7,8-dimethoxy-3-<3-<<4-(1H-imidazol-1-yl)butyl>methylamino>propyl>-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one | 106891-22-9

中文名称
——
中文别名
——
英文名称
7,8-dimethoxy-3-<3-<<4-(1H-imidazol-1-yl)butyl>methylamino>propyl>-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one
英文别名
1-(7,8-Dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-on-3-yl)-3-[N-methyl-N-(4-(imidazolyl-1)-butyl)-amino]propane;3-[3-[4-imidazol-1-ylbutyl(methyl)amino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one
7,8-dimethoxy-3-<3-<<4-(1H-imidazol-1-yl)butyl>methylamino>propyl>-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one化学式
CAS
106891-22-9
化学式
C23H34N4O3
mdl
——
分子量
414.548
InChiKey
PHRTXJLZZXCOIC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    30
  • 可旋转键数:
    11
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    59.8
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    1-(4-chlorobutyl)-1H-imidazole3-(3-(甲基氨基)丙基)-1,3,4,5-四氢-7,8-二甲氧基-2H-3-苯并氮杂卓-2-酮盐酸盐potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 2.0h, 以44%的产率得到7,8-dimethoxy-3-<3-<<4-(1H-imidazol-1-yl)butyl>methylamino>propyl>-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one
    参考文献:
    名称:
    Specific bradycardic agents. 2. Heteroaromatic modifications in the side chain of specific bradycardic benzazepinones: chemistry, pharmacology, and structure-activity relationships
    摘要:
    Compound 1 (UL-FS 49) has recently been described as the representative of a novel class of antischemic compounds termed ''specific bradycardic agents''. In search of specific bradycardic agents with different pharmacokinetic profiles, heteroaromatic analogues of 1 have been synthesized and evaluated for their bradycardic activity, selectivity, and duration of action. The chain length n and the nature of the heteroaromatic system of compounds 2 strongly determine the biological activities. Unsubstituted benzothiophenes and benzofurans in combination with a chain length of n = 2 give the most active bradycardic compounds. Some of the new compounds combine high bradycardic potency and selectivity with a short duration of action and may thus be useful for the development of short-acting specific bradycardic drugs.
    DOI:
    10.1021/jm00107a011
点击查看最新优质反应信息

文献信息

  • BOMHARD, ANDREAS;REIFFEN, MANFRED;HEIDER, JOACHIM;PSIORZ, MANFRED;LILLIE,+, J. MED. CHEM., 34,(1991) N, C. 942-947
    作者:BOMHARD, ANDREAS、REIFFEN, MANFRED、HEIDER, JOACHIM、PSIORZ, MANFRED、LILLIE,+
    DOI:——
    日期:——
  • US4737495A
    申请人:——
    公开号:US4737495A
    公开(公告)日:1988-04-12
  • Specific bradycardic agents. 2. Heteroaromatic modifications in the side chain of specific bradycardic benzazepinones: chemistry, pharmacology, and structure-activity relationships
    作者:Andreas Bomhard、Manfred Reiffen、Joachim Heider、Manfred Psiorz、Christian Lillie
    DOI:10.1021/jm00107a011
    日期:1991.3
    Compound 1 (UL-FS 49) has recently been described as the representative of a novel class of antischemic compounds termed ''specific bradycardic agents''. In search of specific bradycardic agents with different pharmacokinetic profiles, heteroaromatic analogues of 1 have been synthesized and evaluated for their bradycardic activity, selectivity, and duration of action. The chain length n and the nature of the heteroaromatic system of compounds 2 strongly determine the biological activities. Unsubstituted benzothiophenes and benzofurans in combination with a chain length of n = 2 give the most active bradycardic compounds. Some of the new compounds combine high bradycardic potency and selectivity with a short duration of action and may thus be useful for the development of short-acting specific bradycardic drugs.
查看更多